FOXP3 and breast carcinoma: In breast cancer, an increase in the Treg population, both in peripheral blood and tumour tissue, was also reported and a recent study demonstrated a correlation between intratumoural infiltration of FOXP3+ Tregs in breast cancer and the risk of late relapse[26].